Fu‐Zon Chung

1.8k total citations
38 papers, 1.5k citations indexed

About

Fu‐Zon Chung is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Fu‐Zon Chung has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in Fu‐Zon Chung's work include Receptor Mechanisms and Signaling (22 papers), Neuropeptides and Animal Physiology (15 papers) and Cancer, Stress, Anesthesia, and Immune Response (4 papers). Fu‐Zon Chung is often cited by papers focused on Receptor Mechanisms and Signaling (22 papers), Neuropeptides and Animal Physiology (15 papers) and Cancer, Stress, Anesthesia, and Immune Response (4 papers). Fu‐Zon Chung collaborates with scholars based in United States, Czechia and United Kingdom. Fu‐Zon Chung's co-authors include Claire M. Fraser, J. Craig Venter, Anthony R. Kerlavage, Klaus‐Ulrich Lentes, Michael G. FitzGerald, Doreen Robinson, P C Potter, Yannick P. Maneuf, Maria Gonzalez and R.D. Pinnock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Fu‐Zon Chung

37 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fu‐Zon Chung United States 20 897 521 208 201 182 38 1.5k
Akiko Watabe Japan 14 838 0.9× 293 0.6× 331 1.6× 210 1.0× 57 0.3× 29 1.7k
John DelValle United States 23 913 1.0× 382 0.7× 249 1.2× 387 1.9× 31 0.2× 39 2.7k
Heather A Wilson United States 17 656 0.7× 296 0.6× 205 1.0× 232 1.2× 65 0.4× 19 1.3k
Torik Ayoubi Belgium 25 1.3k 1.5× 231 0.4× 226 1.1× 165 0.8× 67 0.4× 41 2.2k
Jun Utsumi Japan 21 676 0.8× 195 0.4× 178 0.9× 181 0.9× 17 0.1× 55 1.3k
Guo-Huang Fan China 26 1.2k 1.3× 532 1.0× 312 1.5× 678 3.4× 43 0.2× 43 2.3k
Ximena Opitz-Araya United States 8 1.4k 1.6× 157 0.3× 86 0.4× 234 1.2× 72 0.4× 8 2.0k
Bin Yin China 29 1.8k 2.0× 133 0.3× 153 0.7× 153 0.8× 78 0.4× 113 2.4k
Shun‐ichiro Matsumoto Japan 18 1.1k 1.2× 316 0.6× 361 1.7× 673 3.3× 14 0.1× 23 2.3k
Jean‐Luc Parent Canada 29 1.8k 2.0× 604 1.2× 253 1.2× 285 1.4× 64 0.4× 65 2.4k

Countries citing papers authored by Fu‐Zon Chung

Since Specialization
Citations

This map shows the geographic impact of Fu‐Zon Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu‐Zon Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu‐Zon Chung more than expected).

Fields of papers citing papers by Fu‐Zon Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fu‐Zon Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu‐Zon Chung. The network helps show where Fu‐Zon Chung may publish in the future.

Co-authorship network of co-authors of Fu‐Zon Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Fu‐Zon Chung. A scholar is included among the top collaborators of Fu‐Zon Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fu‐Zon Chung. Fu‐Zon Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Ting‐Hua, Angela Yen, Lifu Chen, et al.. (2024). Critical role of hepsin/TMPRSS1 in hearing and tectorial membrane morphogenesis: Insights from transgenic mouse models. Hearing Research. 453. 109134–109134.
2.
Kiel, Mark J., Anagh A. Sahasrabuddhe, Delphine Rolland, et al.. (2015). Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome. Nature Communications. 6(1). 8470–8470. 143 indexed citations
3.
Chung, Fu‐Zon, et al.. (2008). Development of a robust GABABcalcium signaling cell line using β‐lactamase technology and sorting. Cytometry Part A. 73A(8). 761–766. 4 indexed citations
4.
Chung, Fu‐Zon, et al.. (2003). Cellular and molecular action of the putative GABA-mimetic, gabapentin. Cellular and Molecular Life Sciences. 60(4). 742–750. 124 indexed citations
6.
Chung, Fu‐Zon, Helen T. Lee, W. Thomas Mueller, et al.. (1998). Bacterial Expression and Characterization of Human Recombinant Apolipoprotein(a) Kringle IV Type 9. Protein Expression and Purification. 13(2). 222–228. 1 indexed citations
7.
Chung, Fu‐Zon, et al.. (1997). Cloning, expression and characterization of a human dopamine D402 receptor (CHO K1 cells) and various D4.2/D2L chimeras (COS-7 cells). Progress in Neuro-Psychopharmacology and Biological Psychiatry. 21(1). 153–167. 8 indexed citations
8.
Mei, Houng‐Yau, et al.. (1996). Inhibition of Self-Splicing Group I Intron RNA: High-Throughput Screening Assays. Nucleic Acids Research. 24(24). 5051–5053. 15 indexed citations
10.
Jonat, Carsten, Fu‐Zon Chung, & Vijaykumar M. Baragi. (1996). Transcriptional downregulation of stromelysin by tetracycline. Journal of Cellular Biochemistry. 60(3). 341–347. 42 indexed citations
11.
Chung, Fu‐Zon, Yuan Tian, Maida Vartanian, et al.. (1995). Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptor.. Molecular Pharmacology. 48(4). 711–716. 39 indexed citations
12.
Reynolds, Elwood E., O. Hwang, Mary Flynn, et al.. (1995). Pharmacological Differences Between Rat and Human Endothelin B Receptors. Biochemical and Biophysical Research Communications. 209(2). 506–512. 27 indexed citations
13.
Pinnock, Robert D., Nirmala Suman‐Chauhan, Fu‐Zon Chung, et al.. (1994). Characterization of tachykinin mediated increases in [Ca2+]i in Chinese hamster ovary cells expressing human tachykinin NK3 receptors. European Journal of Pharmacology Molecular Pharmacology. 269(1). 73–78. 18 indexed citations
14.
Chung, Fu‐Zon, Maida Vartanian, Keith J. Watling, et al.. (1994). The Nonpeptide Tachykinin NK2 Receptor Antagonist SR 48968 Interacts with Human, but Not Rat, Cloned Tachykinin NK3 Receptors. Biochemical and Biophysical Research Communications. 198(3). 967–972. 24 indexed citations
15.
Potter, Paul C., et al.. (1993). Absence of functional inhibition of cloned human β2‐adrenergic receptors by autoantibodies in asthmatic subjects. Clinical & Experimental Allergy. 23(3). 219–225. 2 indexed citations
17.
Lentes, Klaus‐Ulrich, et al.. (1988). A biallelic DNA polymorphism of the human beta-2-adrenergic receptor detected by Ban I-Adrbr-2. Nucleic Acids Research. 16(5). 2359–2359. 27 indexed citations
18.
Lai, Josephine, et al.. (1988). The cloned murine M1 muscarinic receptor is associated with the hydrolysis of phosphatidylinositols in transfected murine B82 cells. Life Sciences. 42(24). 2489–2502. 43 indexed citations
19.
Kerlavage, Anthony R., Claire M. Fraser, Fu‐Zon Chung, & J. Craig Venter. (1986). Molecular structure and evolution of adrenergic and cholinergic receptors. Proteins Structure Function and Bioinformatics. 1(4). 287–301. 21 indexed citations
20.
Chung, Fu‐Zon, et al.. (1986). Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.. PubMed. 11(5). 345–54. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026